Arovella Therapeutics Limited

ASX:ALA Stock Report

Mkt Cap: AU$21.9m

Arovella Therapeutics Financial Health

How is Arovella Therapeutics's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ALA's short term assets (A$6.6M) exceed its short term liabilities (A$1.5M).

Long Term Liabilities: ALA's short term assets (A$6.6M) exceed its long term liabilities (A$86.8K).


Debt to Equity History and Analysis

Debt Level: ALA is debt free.

Reducing Debt: ALA has no debt compared to 5 years ago when its debt to equity ratio was 10.7%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALA has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ALA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.7% each year


Discover healthy companies